Breast Cancer Clinical Trial
Official title:
Development of an Aerobic and Resistance Training Feasibility Study for a Racially and Ethnically Diverse Sample of Breast Cancer Survivors
The goal of this behavioral research study is to find out more about the health behaviors of cancer survivors. Researchers want to understand the cultural, social, and environmental factors related to physical activity and personal diet. Researchers also want to learn if cancer survivors who take part in lifestyle interventions have better overall health and quality of life than those who do not take part in these interventions.
If you agree to take part in this study, you will have a baseline study visit. This visit
will include a physical exam, including measurements of your height and weight. Your hips,
wrist, mid-arm, and waist will also be measured. You will also fill out questionnaires that
contain items about your diet and exercise habits as well as questions about your quality of
life.
Study Groups:
You will be randomly assigned (as in the flip of a coin) to 1 of 2 groups.
- Group 1 will take part in an exercise intervention program.
- Group 2 will take part in a sedentary behavior and dietary intervention group.
Group 1--Exercise Intervention:
At the baseline study visit, the study staff will show you how to complete the physical
exercises you will perform while you are on study.
You will receive a pedometer that you can wear on your waistband to track your physical
activity. The pedometer is the size of a deck of cards and will be worn throughout the study
to track your progress.
You will be given resistance training bands to use as part of the home-based exercise
program. At the baseline study visit, you will receive a directions on how to use the study
website. In addition, the study coordinator will walk you through each of these exercises.
After the study is complete, you will be allowed to keep the resistance training bands and
pedometer.
Participants in Groups 1 will receive access to a website that will allow you to track your
exercise behavior and help you set goals. This data will be recorded for you, and your
progress will be graphed throughout the course of the study.
You will be given access to an internet-based curriculum that will help teach you about
goal-setting, overcoming barriers to physical activity, self-management strategies, and
time-management skills. You are being asked to visit the website every week to read that
week's lesson materials and to set weekly goals. In addition to this weekly visits, you will
need to record your activity and the number of steps you take every day on the website. Each
month, you will be asked to fill our a survey about your attitudes and beliefs about
physical activity.
Group 2--Parallel-Study Group:
Participants who are assigned to this group will received access to the same website as
Group 1. You will also be asked to read information about improving the quality of your diet
and cutting back on sedentary behavior ( for example, television viewing and overall
sitting). The website will allow you to track your sitting and dietary behaviors and help
you set goals. This data will be recorded for you, and your progress will be graphed
throughout the course of the study.
Participants in Group 2 will be given access to curriculum that will help teach you about
goal-setting, overcoming barriers to improving your diet and cutting back on sedentary
behavior, as well as learn self-management strategies and time-management skills. You are
being asked to visit the website once a week to read that week's lesson materials and to set
weekly goals. In addition to this weekly visit, you will need to record on the website how
much television you watch and how many fruits and vegetables you eat every day. Each month,
you will be asked to fill our a survey about your attitude and beliefs about sedentary
behavior and dietary intake.
6-Month Follow-up Visit: For both groups (Groups 1 & 2), at the 6-month follow-up visit,
your weight and waist, hip, and arm measurements will be recorded and compared to your
measurements from the baseline visit.
Length of Study:
For both groups, you will be taken off study if you experience side effects from taking part
in the intervention, you are hospitalized for any reason, or you are diagnosed with a
condition that needs a treatment not allowed while on this study.
Your participation on the study will be over once you have completed the 6-month visit.
This is an investigational study.
Up to 200 cancer survivors will take part in this study. Up to 150 will be enrolled at MD
Anderson.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04681911 -
Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer
|
Phase 2 | |
| Terminated |
NCT04066790 -
Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
|
Phase 2 | |
| Completed |
NCT04890327 -
Web-based Family History Tool
|
N/A | |
| Completed |
NCT03591848 -
Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility
|
N/A | |
| Recruiting |
NCT03954197 -
Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients
|
N/A | |
| Terminated |
NCT02202746 -
A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer
|
Phase 2 | |
| Active, not recruiting |
NCT01472094 -
The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
|
||
| Completed |
NCT06049446 -
Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
|
||
| Withdrawn |
NCT06057636 -
Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study
|
N/A | |
| Recruiting |
NCT05560334 -
A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations
|
Phase 2 | |
| Active, not recruiting |
NCT05501769 -
ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer
|
Phase 1 | |
| Recruiting |
NCT04631835 -
Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer
|
Phase 1 | |
| Completed |
NCT04307407 -
Exercise in Breast Cancer Survivors
|
N/A | |
| Recruiting |
NCT03544762 -
Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation
|
Phase 3 | |
| Terminated |
NCT02482389 -
Study of Preoperative Boost Radiotherapy
|
N/A | |
| Enrolling by invitation |
NCT00068003 -
Harvesting Cells for Experimental Cancer Treatments
|
||
| Completed |
NCT00226967 -
Stress, Diurnal Cortisol, and Breast Cancer Survival
|
||
| Recruiting |
NCT06019325 -
Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy
|
N/A | |
| Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
| Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 |